Related Experiment Videos
Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia
H H J Leliefeld1, H J Stoevelaar, J McDonnell
1Department of Urology, Laurentius Hospital Roermond, and Institute for Health Care Policy and Management, Erasmus University Rotterdam, The Netherlands. h.leliefeld@lzr.nl
BJU International
|February 22, 2002
Summary
Most men with benign prostatic hyperplasia (BPH) experienced stable sexual function after treatment. Treatments for BPH showed similar rates of positive and negative sexual changes, challenging previous reports of adverse events.
Area of Science:
- Urology
- Andrology
- Pharmacology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Sexual dysfunction is a potential concern for patients undergoing BPH treatment.
Purpose of the Study:
- To evaluate the impact of different benign prostatic hyperplasia (BPH) treatments on male sexual function.
- To compare sexual function outcomes across various BPH therapeutic modalities.
Main Methods:
- A longitudinal, multicenter study involving 670 men aged 50+ with BPH.
- Patients completed validated questionnaires assessing sexual function at baseline and 9 months post-treatment.
- Data on symptomatology, bothersomeness, and sexual function were collected and analyzed.
Main Results:
- At baseline, 49-59% reported normal potency and 69% normal libido.
- After 9 months, 84% of patients reported no changes in sexual function.
- All treatments resulted in both improvements (3-14%) and deteriorations (0-16%) in sexual function.
Conclusions:
- The majority of patients maintain stable sexual function following BPH treatment.
- Positive and negative sexual function changes occurred with similar frequency across all treatment groups.
- Findings suggest a lower incidence of sexual adverse events than previously reported, particularly with surgical interventions.